NYU Langone Health plans will adopt Philips’ IntelliSite Pathology solution, enterprise informatics, Philips Lumify Handheld Ultrasound, Philips Patient Information Center iX and the Philips Capsule MDIP
The exterior view of NYU Langone Health’s building. (Credit: Koninklijke Philips N.V.)
Dutch healthcare firm Royal Philips has said that the American academic medical centre NYU Langone Health is adopting its health technology solutions in an eight-year strategic partnership, valued up to $115m, to improve patient safety, care, quality and outcomes.
Under the partnership, NYU Langone Health plans will adopt Philips’ IntelliSite Pathology solution, enterprise informatics, and artificial intelligence (AI)-enabled diagnostic imaging technologies like the Philips Lumify Handheld Ultrasound.
NYU Langone will also use the Philips Patient Information Center iX and the Philips Capsule Medical Device Information Platform (MDIP) to streamline workflows and use the data power.
MDIP is designed to create a single, unified view by combining heterogeneous data from medical devices and systems, according to the Dutch healthcare major.
The bundled solutions are meant to offer smooth network interaction when used with Philips PIC iX in a predictable Enterprise Monitoring as a Services (EMaaS) subscription model.
NYU Langone chief digital and information officer Nader Mherabi said: “As one of the most digitally advanced health systems in the nation, NYU Langone Health empowers our clinicians to easily transform data into insights that can help us further elevate the world-class care and exceptional outcomes we provide to our patients.
“Further harnessing big data is the next step in our commitment to ensuring that NYU Langone remains at the forefront of innovation and precision medicine that our patients have to come to expect.”
Philips said the collaboration will help the firm to collect patient data for precision diagnosis and treatment.
The latest technology enables real-time collaboration amongst NYU Langone clinicians, facilitating the sharing of pathology reports, imaging studies, and patient data.
This integrated, multidisciplinary strategy will contribute to the effort to improve patient outcomes and experience by enabling quicker diagnosis and treatment, the healthcare company said.
NYU Langone aims to streamline processes, standardise patient monitoring systems, and establish standards-based interoperability using its electronic medical record (EMR).
Philips Connected Care chief business leader Julia Strandberg said: “With the adoption of these technologies, they are the forefront of leveraging a new enterprise monitoring platform and business model to help enable a better patient experience, improved staff productivity and reduced cost of care.”